# Microdosing GLP-1 and Hair Loss: What Research Shows

**By telos rx Editorial Team** · 2026-11-13

**Microdosing GLP-1 and hair loss have not been studied together. FDA labels report hair loss at standard doses and link it to weight reduction. Nobody knows yet whether a lower dose changes that risk. [Microdosed tirzepatide from telos rx](https://telosrx.com/pages/microdosed-tirzepatide) is prescribed for weight management only.**

Hair shedding is one of the most searched worries about GLP-1 medications. It is also one of the most emotional. Below, you will see what the labels and reviews actually say, why shedding tends to happen, and what to ask your provider.

## What microdosing means here

Microdosing is not an FDA-recognised dosing category. It means a provider-prescribed dose below the standard labelled titration schedule. That is off-label use.

The published evidence for sub-label doses is limited. Compounded tirzepatide is not FDA-approved, and it is not the same product as Zepbound or Mounjaro. Every hair loss figure you will see below comes from standard doses.

New to the term? Start with [what counts as a microdose of tirzepatide](/blogs/glp1/what-is-a-microdose-of-tirzepatide).

## Does microdosing GLP-1 cause hair loss?

Here is the short, honest answer. Hair loss is a listed side effect of GLP-1 medications at labelled doses. No study has measured hair loss at microdoses.

So we cannot tell you that a microdose avoids it. We also cannot tell you that a microdose causes it at the same rate. The data simply do not exist yet.

What the evidence does suggest is that hair loss on these drugs is closely tied to weight reduction itself. That matters, and we will unpack it below.

## What the research shows: four findings

Each finding below is framed as evidence, not a prediction of what will happen to you.

| Source | Design | Dose studied | Microdose data? |
| --- | --- | --- | --- |
| Zepbound FDA label | Pooled trial data | Labelled doses | No  |
| Wegovy FDA label | Pooled trial data | Labelled doses | No  |
| Alsuwailem et al., 2025 | Systematic review, 5 studies | Mostly weekly tirzepatide | No  |
| Bridges and Jackson, 2026 | Dermatology review | Standard doses | No  |

### Finding 1: the tirzepatide label links hair loss to weight reduction

The Zepbound label lists hair loss among its common adverse reactions ([DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)). It states that hair loss in treated patients was associated with weight reduction.

The label also reports that hair loss was more common in women than in men, in both the drug and placebo groups. No Zepbound-treated patient in that pooled data stopped treatment because of hair loss.

### Finding 2: the semaglutide label shows a similar pattern

The Wegovy label also lists hair loss and ties it to weight reduction. In its trial tables, hair loss was reported more often at the higher Wegovy dose than at the lower one, and least often on placebo.

That hints that dose and the amount of weight lost may matter. It does not tell us what happens below the labelled schedule. Nobody has tested that.

### Finding 3: a systematic review found conflicting results

A 2025 systematic review pulled together studies on hair loss and GLP-1 drugs ([Alsuwailem et al., 2025](https://pubmed.ncbi.nlm.nih.gov/41111833/)). It included five studies, mostly involving weekly subcutaneous tirzepatide.

The authors described conflicting findings. Some studies reported hair loss as an adverse event. Others reported the opposite pattern. The authors called for more research to clarify the link.

Note the limits. Five studies is a small base, and none tested microdoses. Conflicting results mean nobody should claim GLP-1 drugs are good or bad for hair from this review.

### Finding 4: dermatologists point to telogen effluvium

A 2026 dermatology review looked at hair and scalp effects of GLP-1 drugs in practice ([Bridges and Jackson, 2026](https://pubmed.ncbi.nlm.nih.gov/42767469/)). It described hair loss as an emerging and clinically significant adverse effect seen across pivotal trials.

The authors named telogen effluvium as the main mechanism. That is shedding triggered by rapid weight loss and calorie restriction. They also discussed hormonal shifts, nutrition gaps and possible direct effects on the hair follicle.

The review covered management too: nutrition review, counselling on the expected course of shedding, and prescription options a dermatologist may discuss. It did not study microdoses.

## Why hair shedding happens during weight loss

Each hair cycles through a growth phase and a resting phase. A big stressor can push many hairs into the resting phase at once. Some time later, they shed together.

That is telogen effluvium. Common triggers include rapid weight loss, a sharp drop in calories, illness, surgery and major stress. Bariatric surgery is well known for it, too.

It tends to show up as more hair in the brush or shower drain. It is usually diffuse, not patchy. Dermatology reviews describe it as usually temporary once the trigger settles.

Because of the delay, people often blame whatever changed most recently. The real trigger may have been weeks earlier. That is one more reason to keep a simple log.

### Why this matters for microdosing

If shedding mostly follows the speed and depth of weight loss, then the drug dose is only part of the story. How fast you lose, how much you eat and how much protein you get may matter as well.

That is a hypothesis, not a finding. No trial has tested whether a slower, lower-dose approach changes hair outcomes. Read any claim that it does with caution.

## How to track your hair calmly

Worry about hair can make every strand in the sink feel like a crisis. Some daily shedding is normal for everyone. A simple record helps you and your provider see real change.

-   Take a photo of your part line in the same light once a month.
-   Note any new medications, illness or major stress.
-   Log your weight trend, not just single readings.
-   Write down roughly what you eat on a typical day.
-   Note when you first noticed more shedding.

This record turns a vague worry into useful information. It also helps a dermatologist tell shedding apart from slow thinning.

## Who may want extra caution

Some people have more reason to raise hair concerns before starting any GLP-1 plan. That includes anyone with past telogen effluvium, known pattern thinning or a thyroid condition.

The same goes for people with heavy periods or low iron in the past. If that sounds like you, mention it clearly in your intake. Your provider can plan labs and check-ins with that history in mind.

Weight management with a provider who checks in

telos rx offers compounded microdosed tirzepatide for weight management, subject to medical approval by a licensed provider. As low as $116 per month as of publication.

[See microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide)

## Microdosing tirzepatide hair loss: what telos rx can and cannot say

telos rx prescribes microdosed tirzepatide for weight management only. It is not prescribed for hair loss, and it is not marketed as a way to avoid hair loss. Every plan is subject to medical approval by a licensed provider.

The process is asynchronous. You complete an online intake on your own time. A licensed provider reviews your history and messages you with a decision and any follow-up questions.

If prescribed, it is a weekly subcutaneous injection. Your provider sets and adjusts the dose. Medication ships ready to inject, so there is no mixing or dose math at home.

If you notice shedding, message your provider. They can review your intake, your rate of weight change and whether you need labs or a dermatology referral.

For the standard-dose picture, read our guide to [tirzepatide hair loss](/blogs/glp1/tirzepatide-hair-loss).

## Microdosing semaglutide hair loss

Many searches ask about semaglutide specifically. The evidence picture is the same. Hair loss appears on the Wegovy label at standard doses, and no study has measured it at microdoses.

telos rx does not offer a microdosed semaglutide product. The telos rx microdose option is tirzepatide. For more on semaglutide and shedding, see [does semaglutide cause hair loss](/blogs/glp1/does-semaglutide-cause-hair-loss).

## Where there is no microdose data

As of publication, we found no published study that measured hair loss at intentional GLP-1 microdoses.

-   No microdose data on how often shedding happens.
-   No microdose data on how long shedding lasts.
-   No data comparing slow, low-dose plans with standard titration for hair.
-   No data on whether women are affected differently at low doses.
-   No microdose data on regrowth after shedding.

Some clinics market microdosing as a way to keep your hair. That claim has no direct evidence behind it. GLP-1 medications are not FDA-approved for any hair condition.

## Other causes of hair loss worth ruling out

Not all hair loss during weight loss comes from the medication or the weight change. Midlife hair changes have many causes, and some need their own care.

-   **Thyroid problems.** Both underactive and overactive thyroid can thin hair.
-   **Low iron stores.** Common in people with heavy periods.
-   **Hormone shifts.** Perimenopause, postpartum changes and stopping birth control can all play a role.
-   **Pattern hair loss.** Genetic thinning can become more visible with age.
-   **Stress or illness.** These are classic triggers for shedding.
-   **Other medications.** Some drugs list hair loss as a side effect.

A clinician may suggest blood work to check thyroid function, iron and other markers. Patchy hair loss, scalp pain or scarring deserves a dermatology visit, not a wait-and-see approach.

## Nutrition questions to raise with your provider

GLP-1 medications can make you eat less. That is part of how they work. It also means it is easier to fall short on protein and key nutrients.

The 2026 dermatology review discussed protein targets and nutrition review as part of managing shedding. Ask your provider or a dietitian what a reasonable protein intake looks like for you.

A few practical habits many people find useful:

-   Build each meal around a protein source first.
-   Keep easy protein options on hand for low-appetite days.
-   Do not skip meals entirely when appetite is low.
-   Drink enough fluids, especially if you have nausea.
-   Ask before starting supplements, since some interact with labs or medications.

## Questions to ask before you start

1.  How will we pace my weight loss to limit stress on my body?
2.  Should I get baseline labs, such as thyroid and iron?
3.  What protein intake makes sense for me?
4.  What should I do if I notice more shedding?
5.  When would you refer me to a dermatologist?

For broader side effect context, read [microdosing GLP-1 side effects](/blogs/glp1/microdose-glp1-side-effects) and our explainer on [GLP-1 hair loss causes and management](/blogs/glp1/glp1-hair-loss-causes-timeline-how-to-manage).

## When to talk to a dermatologist

Most diffuse shedding linked to weight loss is temporary. Still, some signs mean you should not wait.

-   Patchy bald spots or broken hairs.
-   Redness, scaling, pain or itching on the scalp.
-   Shedding that keeps going well after your weight settles.
-   Thinning at the part or crown that keeps progressing.
-   Hair loss along with fatigue, cold intolerance or heavy periods.

A dermatologist can look closely at your scalp and order the right tests. They can also discuss prescription options if needed. Bring a list of your medications, including your GLP-1 and any dose changes.

## The bottom line

Microdosing GLP-1 and hair loss is an open question. Labels report shedding at standard doses and tie it to weight reduction. Reviews describe telogen effluvium as the main driver and call for more research.

If weight management is your goal, a licensed provider can review whether microdosed tirzepatide fits you. If hair loss is your main concern, raise it with your own clinician or a dermatologist. Individual responses vary.

Raise your concerns before you start

Start a private, asynchronous evaluation and tell your provider about any hair history. Every plan is subject to medical approval by a licensed provider.

[Check if you qualify](https://telosrx.com/pages/microdosed-tirzepatide)

## Frequently Asked Questions

### Does microdosing GLP-1 cause hair loss?

No study has measured hair loss at GLP-1 microdoses, so nobody can say for sure. FDA labels list hair loss at standard doses and link it to weight reduction. Reviews point to telogen effluvium, a temporary shedding triggered by rapid weight loss. Raise any hair history with your provider before starting.

### Is microdosing tirzepatide hair loss less likely than at full doses?

It has not been tested. The Wegovy label reported hair loss more often at a higher dose than a lower one, which hints that dose may matter. But that comparison was between labelled doses, not microdoses. Claims that microdosing protects your hair have no direct evidence.

### Does microdosing semaglutide hair loss happen too?

The Wegovy label lists hair loss at standard doses and ties it to weight reduction. There is no published data on hair loss at semaglutide microdoses. telos rx does not offer a microdosed semaglutide product. Its microdose option is compounded tirzepatide, which is not FDA-approved.

### Will my hair grow back after GLP-1 shedding?

Dermatology reviews describe telogen effluvium as usually temporary once the trigger settles. But hair loss can have other causes, such as thyroid issues, low iron or genetic thinning. If shedding continues, is patchy or affects your scalp, see a dermatologist for a proper assessment.

### Should I stop my GLP-1 if my hair is shedding?

Do not stop or change a prescription on your own. Message your provider first. They can review your rate of weight change, nutrition and labs, and decide whether a dose change or a dermatology referral makes sense. Any adjustment is subject to medical approval by a licensed provider.

### Can a GLP-1 help hair regrowth?

A 2025 systematic review found conflicting results, with a few reports of regrowth and others of hair loss. That is not enough to support any hair claim. GLP-1 medications are not FDA-approved for any hair condition. telos rx prescribes microdosed tirzepatide for weight management only.

_telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service._

Ready to see if it fits? [Start your private evaluation with telos rx](https://telosrx.com/pages/microdosed-tirzepatide).

**Tags:** cc-112, content-calendar, GLP-1 microdosing, GLP-1 side effects, hair loss, microdosed tirzepatide, microdosing-cluster, research review, telogen effluvium

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/microdosing-glp-1-and-hair-loss)
